Results
|
|
1.
|
|
|
|
2.
|
|
|
|
3.
|
|
|
|
4.
|
An 18F-FDG-PET maximum standardized uptake value > 10 represents a novel valid marker for discerning Richter's Syndrome. [electronic resource] by
- Michallet, Anne-Sophie
- Sesques, Pierre
- Rabe, Kari G
- Itti, Emmanuel
- Tordot, Jérémy
- Tychyj-Pinel, Christelle
- Baseggio, Lucile
- Subtil, Fabien
- Salles, Gilles
- Dupuis, Jehan M
- Conte, Michael J
Producer: 20170106
In:
Leukemia & lymphoma vol. 57
Availability: No items available.
|
|
|
5.
|
Cumulative experience and long term follow-up of pentostatin-based chemoimmunotherapy trials for patients with chronic lymphocytic leukemia. [electronic resource] by
- Kay, Neil E
- LaPlant, Betsy R
- Pettinger, Adam M
- Call, Timothy G
- Leis, Jose F
- Ding, Wei
- Parikh, Sameer A
- Conte, Michael J
- Bowen, Deborah A
- Shanafelt, Tait D
Producer: 20190109
In:
Expert review of hematology vol. 11
Availability: No items available.
|
|
|
6.
|
Outcomes of a large cohort of individuals with clinically ascertained high-count monoclonal B-cell lymphocytosis. [electronic resource] by
- Parikh, Sameer A
- Chaffee, Kari G
- Larson, Melissa C
- Hampel, Paul J
- Call, Timothy G
- Ding, Wei
- Kenderian, Saad S
- Leis, Jose F
- Chanan-Khan, Asher A
- Conte, Michael J
- Bowen, Deborah
- Schwager, Susan M
- Slager, Susan L
- Hanson, Curtis A
- Kay, Neil E
- Shanafelt, Tait D
Producer: 20190719
In:
Haematologica vol. 103
Availability: No items available.
|
|
|
7.
|
Chemoimmunotherapy for relapsed/refractory and progressive 17p13-deleted chronic lymphocytic leukemia (CLL) combining pentostatin, alemtuzumab, and low-dose rituximab is effective and tolerable and limits loss of CD20 expression by circulating CLL cells. [electronic resource] by
- Zent, Clive S
- Taylor, Ronald P
- Lindorfer, Margaret A
- Beum, Paul V
- LaPlant, Betsy
- Wu, Wenting
- Call, Timothy G
- Bowen, Deborah A
- Conte, Michael J
- Frederick, Lori A
- Link, Brian K
- Blackwell, Sue E
- Veeramani, Suresh
- Baig, Nisar A
- Viswanatha, David S
- Weiner, George J
- Witzig, Thomas E
Producer: 20141009
In:
American journal of hematology vol. 89
Availability: No items available.
|
|
|
8.
|
Liver dysfunction in chronic lymphocytic leukemia: Prevalence, outcomes, and pathological findings. [electronic resource] by
- Hampel, Paul J
- Chaffee, Kari G
- King, Rebecca L
- Simonetto, Douglas
- Larson, Melissa C
- Achenbach, Sara
- Call, Timothy G
- Ding, Wei
- Kenderian, Saad S
- Leis, Jose F
- Chanan-Khan, Asher A
- Bowen, Deborah A
- Conte, Michael J
- Schwager, Susan M
- Hanson, Curtis A
- Slager, Susan L
- Kay, Neil E
- Shanafelt, Tait D
- Parikh, Sameer A
Producer: 20171128
In:
American journal of hematology vol. 92
Availability: No items available.
|
|
|
9.
|
Pembrolizumab in patients with CLL and Richter transformation or with relapsed CLL. [electronic resource] by
- Ding, Wei
- LaPlant, Betsy R
- Call, Timothy G
- Parikh, Sameer A
- Leis, Jose F
- He, Rong
- Shanafelt, Tait D
- Sinha, Sutapa
- Le-Rademacher, Jennifer
- Feldman, Andrew L
- Habermann, Thomas M
- Witzig, Thomas E
- Wiseman, Gregory A
- Lin, Yi
- Asmus, Erik
- Nowakowski, Grzegorz S
- Conte, Michael J
- Bowen, Deborah A
- Aitken, Casey N
- Van Dyke, Daniel L
- Greipp, Patricia T
- Liu, Xin
- Wu, Xiaosheng
- Zhang, Henan
- Secreto, Charla R
- Tian, Shulan
- Braggio, Esteban
- Wellik, Linda E
- Micallef, Ivana
- Viswanatha, David S
- Yan, Huihuang
- Chanan-Khan, Asher A
- Kay, Neil E
- Dong, Haidong
- Ansell, Stephen M
Producer: 20170919
In:
Blood vol. 129
Availability: No items available.
|